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Abstract 
 
Background: Tetralogy of fallot (TOF) is the most common cyanotic congenital heart disease. Anesthesia induc-
tion is a challenging issue in these patients due to the risk of worsening hypoxemia following decrease in pulmo-
nary blood flow. We evaluated the effect of three anesthetic induction regimens on the arterial oxygen saturation 
(SaO2%) in children with TOF. 
 
Methods: Seventy six children aged 50 days to 15 years old with TOF, scheduled in Nemazee and Faghihi 
hospitals to undergo elective cardiac surgery during 1385-1388 were randomly divided into 3 groups to receive 
three anesthetic induction agents including ketamine (2 mg/kg, IV), ketamine (5 mg/kg, IM) and halothane for gas 
induction. SaO2% and heart rate were recorded before induction and thereafter every 1 minute during induction 
of anesthesia till 10 min post-induction.  
 
Results: There were not significant differences between three groups regarding pattern of changes in SaO2% 
during 10 min post-induction. All three groups showed an increase in SaO2% committed over 6
th minute but this 
pattern was not seen after that time. In addition, there were not significant differences among groups according 
to heart rate in the study period. 
 
Conclusion: It seems that anesthesia induction in TOF patients with ketamine IV and IM and halothane did not 
have significant adverse effects on SaO2%. Indeed, oxygenation during induction may offset other possible 
adverse effects of induction drugs on SaO2%. 
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Introduction 
 
Tetralogy of fallot (TOF) is the most common cya-
notic congenital heart disease (CCHD) which charac-
terized by a large single ventricular septal defect 
(VSD), an overridden aorta, obstruction to right ven-
tricular out flow and right ventricular hypertrophy. 
Hypercyanotic attacks in TOF patients are common 
and characterized by sudden spells of hypoxemia due 
to a sudden decrease in pulmonary blood flow (PBF). 
Surgical interventions in these patients include total 
correction and some palliative procedures to increase 
PBF transiently.
1  
Anesthesia management in these patients require 
understanding of the events or drugs that influence 
the magnitude of right to left (Rt to Lt) shunting of 
blood, right ventricular outflow obstruction (affected 
by myocardial contractility) and resulting PBF and 
arterial oxygen saturation (SaO2%). Both intravenous 
(IV) and inhalational anesthetic regimens have been 
recommended for induction of anesthesia in patients 
with TOF. Ketamine is the suggested anesthetic drug 
for induction due to its beneficial cardiovascular ef-
fect on increasing systemic vascular resistance (SVR) 
and resulting decreased Rt to Lt shunting via VSD 
and improved oxygenation due to increased PBF. On 
the other hand, ketamine can cause infundibular car-
diac muscle spasm via its positive inotropic effect. 
Anesthetic induction with volatile agents such as   
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sevoflurane and halothane are acceptable but have 
some adverse and/or beneficial effects on PBF and 
SaO2%.
2  
Therefore in the present study, we designed a way 
to compare SaO2% during anesthesia induction with 
three different regimens of anesthetic induction con-
sisting of IV ketamine, ketamine intramuscularly (IM) 
and gas induction with halothane in infants and chil-
dren with TOF anomaly underwent cardiac surgery.  
 
 
Materials and Methods  
 
After approval from the institutional review board, 
ethical committee and getting parental consent, 76 
infants and children aged 50 days to 15 years old with 
diagnosis of TOF and positive history of hypercya-
notic spell presenting for elective cardiac surgery in 
Nemazee and Faghihi hospitals in Shiraz, southern 
Iran affiliated to Shiraz University of Medical Sci-
ences were enrolled during 2007 -2010. Patients with 
history of previous palliative cardiac surgery were 
excluded from the study because they were unlikely 
to have a hypercyanotic spells. Also patients with any 
lung disease were excluded. Infants less than 9 
months and more than 8 y/o received no premedica-
tion and others received midazolam (0.3 mg/kg, max-
imum 15 mg/kg, orally) 30 min prior to induction of 
anesthesia under close observation.  
On arrival in the operating room, the patients were 
placed supine and monitored with a precordial stetho-
scope, ECG, non invasive blood pressure and finger 
probe pulse oximeter (Nellcor Inc, Hayward, CA). In 
all cases, pulse oximeter probe was placed to the right 
thumb. While patients breathing room air, a set of 
baseline data were recorded. The patients were ran-
domized to one of the three study groups for receiv-
ing ketamine (2 mg/kg, IV) in 20 cases (KIV group), 
ketamine (5 mg/kg, IM) in 26 patients (KIM group) 
and gas induction with halothane in 25 cases which 
was incrementally raised from 0.5 to 4% concentra-
tion via a face mask with increasing rate of 0.5% con-
centration each 2-3 breath and then declined to 2% 
immediately after loss of eyelash reflex (H group). 
All patients were oxygenated with oxygen (6-7 
L/min) before and during induction via an appropriate 
sized face mask. An intravenous catheter was placed 
in the ward before arriving to the operating room in 
each patient. Oral endotracheal intubation was per-
formed following administration of fentany (l2 μg/kg, 
IV) and pancuronium (0.1 mg/kg, IV) and then an 
intra-arterial line and a central venous line was insert-
ed for all cases. In all children, heart rate (HR) and 
SaO2% were recorded at baseline in awaken state and 
then every 1 min during induction for 10 minutes by a 
person who was blinded to study groups and was not 
involved in anesthesia management. SaO2% deter-
mined by the pulse oximeter was compared with oxy-
gen saturation measured directly by arterial blood gas 
analysis provided by an arterial blood sample from 
the arterial line at 2 time points of operation in all 
patients (Figure 1).  
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Fig. 1: Pattern of changes in arterial oxygen saturation during study period in the three groups. 
Group 1: IV ketamine, group 2: IM ketamine, group 3: Halothane.  
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Collected data were analyzed by SPSS software 
(Version 16, Chicago, IL, USA). Data were presented 
as mean±SD (standard deviation) for quantitative var-
iables and frequency for qualitative ones. Age, 
weight, baseline HR and SaO2% between groups 
were compared by Kruskal-Wallis test. ANOVA with 
repeated measures was used to compare SaO2% time 
course between groups. Sphericity assumption was 
not satisfied, and then adjusted p value given by 
Greenhouse-Geisser was used. Statistical significance 
was assumed to p<0.05.  
 
 
Results 
 
Seventy six patients of the three groups completed the 
study. There were not significant differences in age 
(p=0.140), weight (p=0.072), baseline SaO2% 
(p=0.205) and HR (p=0.164) among groups (Table 1). 
In all groups, SaO2% increased significantly during 
the study time in comparison to awaken measure-
ments when patients breathed room air. ANOVA with 
repeated measures revealed that there were no differ-
ences in the mean of SaO2% over ten minutes be-
tween three groups (F=1.62, df= 2, p= 0.2).  
Figure 1 shows that there was a time trend effect. 
All three groups showed increase of SaO2% commit-
ted over six minutes without significant differences in 
SaO2% between T1 versus T2 (p=0.039), T2 versus 
T3 (p<0.001), T3 versus T4 (p=0.000<0.001), T4 ver-
sus T5 (p=0.001) and T5 versus T6 (p=0.017). But 
this pattern was not seen after that time, in a way as 
p=0.254, 0.138, 0.766, 0.617 and 0.464 between T6 
and T7, T7 and T8, T8 and T9, T9 and T10, T10 and 
T11 respectively. There was no time group interac-
tion effect (F=2.02, df=7.1, p=0.058) and all groups 
had the same time trend over ten minutes. 
Evaluation and comparison of HR between groups 
showed that there were not significant differences 
among groups (p=0.160) during the 10 minutes of the 
study period.  
Discussion 
 
TOF was initially described in the 19
th century as an 
association of four anatomic findings: VSD, subpul-
monary stenosis, aortic override of the ventricular 
septum, and right ventricular (RV) hypertrophy. Pa-
tients with minimal RV outlet obstruction have unre-
stricted PBF and a left to right shunt through the 
VSD. Conversely, patients with severe obstruction 
would be cyanosed with saturation in the 70% to 80% 
range preoperatively as a result of right to left shunt-
ing. RV outlet obstruction is often dynamic and may 
cause profound cyanosis (hypercyanotic spells). 
Management of anesthesia in TOF patients requires a 
thorough understanding of those events and drugs can 
alter the magnitude, of the Rt to Lt shunt. For exam-
ple, when shunt magnitude is acutely increased, there 
are associated decreases in PBF and SaO2%.  
The magnitude of Rt to Lt shunt can be increased by 
(i) Decreased systemic vascular resistance (SVR), (ii) 
Increased pulmonary vascular resistance (PR), and (iii) 
Increased myocardial contractility which attenuates in-
fandibular obstruction to eject of blood by the RV. Pub-
lished reports are inconclusive and controversial with 
regards to the effect of various anesthetic agents on PBF 
and SaO2% in cyanotic congenital heart disease. The 
optimal induction regimen for patients with congenital 
heart disease should maintain cardiovascular stability.  
Ketamine is the recommended anesthetic agent in 
patients with TOF, nevertheless; the use of ketamine 
remains controversial because it increases pulmonary 
arterial pressure in adult patients.
3,4 A small number 
of studies evaluating the effect of ketamine on pul-
monary artery pressure in children showed conflicting 
results.
5-8 Some studies reported that ketamine did not 
alter HR, blood pressure or intracardiac shunt in cya-
notic congenital heart disease either prior to surgical 
repair or after surgical repair.
7,8 Another study also 
showed that ketamine did not increase PR in children 
with pulmonary hypertension undergoing sevoflurane 
anesthesia and spontaneous ventilation.
9  
Table 1: Demographic data and baseline arterial oxygen saturation and heart rate in 
study patients 
  Halothane IM Ketamine  IV Ketamine  
Age (months)  53.6±44.4  55.8±36.4  57.2±40.4 
Weight (kg)  13.7±5.9  13.9±4.1  14.7±8.8 
Baseline HR
a 140±29  132.8±21.8  125.5±24.2 
Baseline SaO2%  75.7±2.7  73.8±2.6  81.4±3.4 
a HR: heart rate, SaO2%: arterial oxygen saturation Anesthesia in tetralogy of fallot 
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The adverse effect of ketamine on PBF (increased 
PR) may be opposed by its increasing effect on SVR 
and decreased magnitude of Rt to Lt shunt. Animal 
investigations suggest that the effects of ketamine on 
PR are complex. It increased concentrations of epi-
nephrine and norepinephrine in plasma and increased 
PR in isolated rat lungs.
10,11 However, later work with 
several animal models reported that ketamine caused 
direct pulmonary artery vasodilatation. This effect is 
endothelium independent and mediated by a reduc-
tion of calcium in vascular smooth muscle cells by 
inhibitions of both voltage-gated calcium influx and 
norepinephrine induced calcium release from intracel-
lular stores.
4-16 Ketamine has also been noted to at-
tenuate endothelium-dependent pulmonary vasorelax-
ation in response to acetylcholine and bradykinin by 
inhibiting both the nitric oxide and the endothelium 
derived hyperpolarized factor components of the re-
sponse.
17,18 Finally, animal data shows ketamine has 
the potential to increase or inhibit pulmonary vasodi-
latation and the clinical effect most likely depends on 
the integration of multiple mechanisms.
9  
In contrast, positive inotropic effect of ketamine 
on myocardium may cause infundibular spasm of 
cardiac muscle and following increasing Rt to Lt 
shunt magnitude, decreased PBF and SaO2%. Intra-
venous and intramuscular injections are acceptable 
routes of administration of ketamine in anesthesia 
induction. It seems that adverse or beneficial hemo-
dynamic effects of IM ketamine appear more gradual 
than IV ketamine. We compare these two routes of 
administration of ketamine in TOF patients regarding 
effect on SaO2% and HR and observed that both 
groups of ketamine (IV and IM) had similar increas-
ing course in SaO2% in comparison to awaken values 
during the first 10 min after induction of anesthesia.  
Gas induction with volatile agents is another ac-
ceptable anesthetic induction regimen in TOF patients. 
We found the similar increasing course of SaO2% in 
TOF children anesthetized with halothane as gas in-
duction in comparison to ketamine groups despite its 
significant vasodilatory effect. A large decrease in 
SVR would be expected to result in a net increase in Rt 
to Lt shunting and aggravated hypoxemia. However, 
decrease in SaO2% was not noticed in any of the pa-
tients in halothane group. This finding was also report-
ed by William and co-workers when compared the ef-
fect of halothane and IM ketamine on SaO2% in chil-
dren with cyanotic congenital heart disease.
19  
There are some explanations for this observation. 
In our patients, tissue oxygen utilization decreased as 
the children progressed from awaken premedicated 
state to the anesthetized situation. This resulted in 
both a decrease in PBF requirement and an increase 
in mixed venous oxygenation. Keeping the PBF con-
stant, a rise in mixed venous oxygenation has been 
shown to increase SaO2% in cyanotic congenital 
heart disease.
20 Another reason may be a decrease in 
RV outlet obstruction due to myocardial depressant 
effect of halothane resulting increase in PBF and 
SaO2%.
21 Finally, halothane induced hypotension 
that might have been due to decreased cardiac output 
rather than a decrease in SVR. Under these condi-
tions, PBF was sufficient to increase SaO2%. This 
possibility is the most likely, because halothane is 
known to produce vasodilatation and a decrease in 
myocardial contractility while maintaining SVR in 
adults and children.
22 
SaO2% is affected by several factors in patients 
with cyanotic congenital heart disease: (i) The in-
spired fraction of O2 (FIO2); (ii) The extent of Rt to 
Lt shunting; (iii) O2 consumption; (iv) Cardiac out-
put; and (v) The mixed venous oxygen tension.
23 If 
the magnitude of Rt to Lt shunt is 35% or less, SaO2% 
would increase when the FIO2 is increased. In our 
study, SaO2% increased in all groups when the FIO2 
increased from 21% (room air) with preoxygenation. 
Although these increased in SaO2%, we were not able 
to conclude that Rt to Lt shunt did not increase with 
any of these anesthetic agents. It should be considered 
that if the degree of Rt to Lt shunt increased during 
induction of anesthesia, this was offset by a concomi-
tant decrease in oxygen consumption and increase in 
cardiac output, both of which increased mixed venous 
O2 saturation of the shunted blood.
24 
There are some limitations and defects in our 
study including unrecorded blood pressure of pa-
tients during study period and possible inaccuracies 
or errors in SaO2% values. Some events such as 
hypothermia, low cardiac output, drug induced 
vasoconstriction, motion artifact (more common 
with finger probe than ear or forehead probes moni-
toring) and sever hypoxia may cause bias or impre-
cision in SaO2% values. We used finger probe 
pulse oximetry while movement of patients was 
inevitable in children especially at the beginning of 
anesthesia induction.  
In conclusion, our study indicated that the use of 
the IV or IM ketamine and halothane as anesthetic 
induction agents did not significantly affect SaO2% 
and all were hinge to especial attention regarding he-
modynamic stability.  Tavakollian et al. 
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